Latest News

  • Prostate Diagnostics, Medical Genetics in Hong Kong, Family Genomics

    Diagnostics World News | Diagnostic news and product launches include prostate cancer diagnostic test gets expanded coverage, Baylor University partners on a Hong Kong center for medical genetics, and Sure Genomics launches a family health app.

    Jul 12, 2016
  • Theranos Founder Elizabeth Holmes Is Barred From Running Lab for 2 Years

    The New York Times | U.S. regulators also revoked the operating license of a Theranos lab and levied a fine. The sanctions were a major setback for the once high-flying blood-testing start-up.

    Jul 8, 2016
  • Functional Finds: Building a Database for Variant Lookup

    Diagnostics World Ranomics is capturing attention with its database of genomic variants. Counting BGI and Veritas among its new customers, the Toronto-based biotech startup plans to model and test every missense mutation to make genetic tests "more accurate and more conclusive than ever."

    Jul 7, 2016
  • MyGene2 Fills a Gap in Gene Discovery for Mendelian Conditions

    Diagnostics World News | The introduction of exome and whole-genome sequencing in 2010 has accelerated the discovery of genes underlying Mendelian disorders. However delineating new Mendelian conditions by comparing phenotypic traits across families is still challenging, especially with limited sharing of health and genetic data among researchers. Researchers at the University of Washington have launched a new data sharing platform to bring family expertise to the table.

    Jul 5, 2016
  • WuXi NextCODE Platform Available on Azure

    Diagnostics World Brief | WuXi NextCODE’s genomics platform is now available on Microsoft Azure. The platform has previously been available on Amazon Web Services and Huawei in China.

    Jun 27, 2016
  • MolecularMD, Illumina Agreement for Companion Diagnostics

    Diagnostics World Brief | MolecularMD Corporation and Illumina are working together to establish a framework for potential collaborations with respect to the development and commercialization of sequencing-based companion diagnostics in support of biopharma drug development programs. The agreement announced today dovetails MolecularMD's companion diagnostic development and FDA submission experience with Illumina's NGS technology.

    Jun 27, 2016
  • Matchmaker Exchange Networks Genetic Databases For Rare Disease Diagnosis

    Diagnostics World | Matchmaker Exchange (MME) aims to create a network that connects several isolated rare disease databases using a common application programming interface (API) that supports queries and responses. If it can provide researchers and clinicians with data from just one more case with a deleterious variant in the same gene and phenotypic features in common, MME may offer sufficient evidence to identify the causative gene for a specific rare disease.

    Jun 23, 2016
  • Quest Diagnostics scoops up Safeway partnership after Theranos fallout

    Becker's Hospital Review | Madison, N.J.-based Quest Diagnostics announced a partnership last week with grocery chain Safeway that will bring diagnostic testing to 12 grocery stores in California, Colorado, Texas, Virginia and Maryland.

    Jun 23, 2016
  • IBM Watson Health Launches Imaging Effort for Cancer Other Diseases

    Xconomy | So far, the story of IBM Watson Health has been mostly about growth and potential. Today, it's more about action. The healthcare computing giant is unveiling a collaborative effort in medical imaging that includes partnerships with health systems, radiology providers, tech companies, and academic medical centers.

    Jun 22, 2016
  • Kailos, Huntsman Cancer Institute Collaborate on Breast Cancer Clinical Grade Circulating Tumor Test

    Diagnostics World | Kailos Genetics and the Huntsman Cancer Institute (HCI) at the University of Utah have won a $2.4 million grant from the National Institutes of Health to develop a clinical-grade test for circulating tumor DNA (ctDNA) to monitor patients for breast cancer disease recurrence.

    Jun 22, 2016
  • Diagnostics Companies on Top 50 List

    MIT Technology Review | The Tech Review editors pick the 50 companies that best combine innovative technology with an effective business model. Several diagnostics and biotech companies make the list, including T2 Biosystems (#34), Oxford Nanopore (#22), and Veritas (#40).

    Jun 21, 2016
  • FDA Grants Emergency Use Authorization to Zika Diagnostic

    Diagnostics World News | On Friday, the U.S. Food and Drug Administration (FDA) granted emergency use authorization for Hologic’s new, diagnostic assay for Zika virus infection.

    Jun 20, 2016
  • Something May Be Working At Theranos But You Dont Know What It Is

    Forbes | Elizabeth Holmes speaking at the Forbes Healthcare Summit last December. Credit: Glen Davis If there is working technology at Theranos, the embattled startup that promised to revolutionize blood tests by replacing needles in veins with finger pricks at a lower price with faster speed, you wouldn't be able to tell. To [...]

    Jun 17, 2016
  • An Epidemic of Septicemia?

    THCB | CDC says that 86% of healthcare dollars are spent on patients with chronic illness, and the largest, fastest, and most preventable diagnosis is the most acute of all: septicemia. 13% of the time, patients die.

    Jun 17, 2016
  • Could CRISPR gene-cutting tool transform disease diagnostics?

    STAT | The gene-editing technique CRISPR has been used for the first time to create a diagnostic that can differentiate between two strains of the Zika virus.

    Jun 15, 2016
  • Walgreens Finally Walked. Heres Why Thats So Bad For Theranos

    Forbes | Yesterday, Walgreens, the U.S. drug-store arm of global pharmacy giant Walgreens Boots Alliance, finally terminated its deal with Theranos, the blood-testing startup that once aimed to disrupt the laboratory business but now is fighting for its survival.

    Jun 13, 2016
  • Invitae Launches Customer Service Toolkit

    Diagnostics World  Invitae Corporation launched CancerCHECK (Cancer Complete Hereditary Evaluation Clinic Kit), this week, a comprehensive toolkit that provides checklists, information, and customized support for clinicians considering genetic testing for hereditary breast, ovarian, and colorectal cancers.

    Jun 8, 2016
  • New blood test may be able to find best antidepressant match study says

    Washington Post | British scientists took a major step toward bringing personalized medicine to mental health on Tuesday, announcing that they had developed a blood test that can accurately predict whether or not you'll respond to the conventional, commonly prescribed antidepressants on the market.

    Jun 8, 2016